Replies to post #5680 on Halozyme Therapeutics Inc (HALO)

[maumar]

I am using Helen's numbers. 80% of $7B peak sales. At 4% it's $224M, $280M at 5%. And we still don't know when SC Darzalex will be approved. I don't think Helen's projections are conservative. Royalties have not grown in the past year or so and we need several new products on the market in the near future to get to $1B by 2017 imo.

https://www.loncarblog.com/halozyme-royalty-revenue